Search Results 1581-1590 of 20770 for Informed consent

1. Clinical Validation of Canon PEI-514VX Transesophageal Transducer (TEE) - Mayo Clinic

   Informed consent understood and signed. The patient will comply with post-treatment follow-up protocol requirements. Exclusion Criteria: Pregnant women and ...

2. A Study of Intravenous Acetaminophen for Small Bowel Obstruction - Mayo Clinic

   Unable to provide informed consent. Eligibility last updated 6/1/23. Questions regarding updates should be directed to the study team contact. Participating ...

3. STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS - Mayo Clinic

   Signed informed consent must be obtained prior to participation in the study. Age ≥ 18 years at the date of signing the informed consent form (ICF).

4. Ischemia Using Sandboxaq Magnetocardiography Device (PRISM) - Mayo Clinic

   Written informed consent. Exclusion Criteria: Present STEMI. Pregnant or breastfeeding. Active thoracic metal implants (including pacemaker, insertable ...

5. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

   Patients must be able to understand be willing to sign a written informed consent document. Patients with impaired decision-making capacity (IDMC) will be ...

6. The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. - Mayo Clinic

   Ability to provide informed consent. Current psychiatric inpatient (voluntary only) or outpatient treatment. Male or female. Age 18-65 years old. Meets DSM ...

7. A Study To Evaluate The Effectiveness Of IDCT (Intradiscal Cell Therapy) In Subjects With One Level, Symptomatic Mild To Moderate Lumbar Degenerative Disc Disease - Mayo Clinic

   All subjects will provide written informed consent prior to Screening. Approximately 162 subjects will be enrolled in the study. Up to 45 days prior to ...

8. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

   Signed informed consent to provide blood sample(s) for specific correlative assays. Exclusion Criteria: Concomitant Kras and BRAF-V600 mutations or MSI-H ...

9. Study of BN Brachyury and Radiation in Advanced Chordoma Patients - Mayo Clinic

   Significant dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent. Active ...

10. A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Able to provide to the Investigator written informed consent regarding the ... consent. Able to safely undergo a bone marrow aspiration. Feeding tube ...